Logo Lucerna-Chem
+41 41 420 9636

Article Status


ML-193


Catalog Number Pack Size List Price* Quantity
HY-110125-5MG 5 mg Inquire
HY-110125-25MG 25 mg Inquire
HY-110125-10MG 10 mg Inquire
HY-110125-50MG 50 mg Inquire
HY-110125-100MG 100 mg Inquire

* CHF, excl. 7.7% VAT and shipping costs


Product Description

CID 1261822
ML-193 (CID 1261822) is a potent and selective antagonist of GPR55, with an IC50 of 221 nM. ML-193 shows more than 27-fold selectivity for GPR55 over GPR35, CB1 and CB2. ML-193 can improve the motor and the sensorimotor deficits of Parkinson’s disease (PD) rats.

Category Biochemicals
Supplier MedChem Express
Application Neuroscience-Neurodegeneration
Regulatory Status RUO
Grade Clinical information: No Development Reported
Molecular Formula C28H25N5O4S
Molecular Weight 527.59
CAS-Number [713121-80-3]
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland